Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cassia alata contains anthraquinones, particularly chrysophanol and aloe-emodin, which demonstrate antifungal activity against dermatophytes. These compounds disrupt fungal cell membranes and inhibit growth of organisms causing ringworm and other fungal skin infections. The plant's flavonoids may provide additional antimicrobial support. As a laxative, the anthraquinones stimulate colonic motility and increase fluid secretion in the intestines. Evidence Level: C, based on in vitro and animal studies with limited human trials.
Does Cassia alata interact with any medications?
Cassia alata may interact with several medication classes when taken internally. Due to its laxative effects, it can reduce absorption of oral medications and may potentiate the effects of diuretics, increasing electrolyte imbalance risk. Concurrent use with cardiac glycosides like digoxin requires caution, as potassium depletion from laxative use can increase drug toxicity. Avoid combining with other stimulant laxatives. Those on heart medications, diuretics, or corticosteroids should consult a healthcare provider before internal use.
What is the correct dosage of Cassia alata leaves?
For fungal skin infections, fresh or dried leaves are crushed into a paste and applied topically to affected areas two to three times daily. For laxative use, 1-2 grams of dried leaves can be prepared as a tea, taken once daily. Internal use should not exceed 7-10 consecutive days without medical supervision. Long-term use can cause electrolyte disturbances and laxative dependence. Evidence Level: C, based primarily on traditional use and limited clinical data.
Is Cassia alata safe to use during pregnancy?
Cassia alata is considered unsafe during pregnancy and should be avoided. The anthraquinone compounds stimulate uterine contractions and may cause miscarriage or premature labor. Additionally, the laxative effects can lead to dehydration and electrolyte imbalances that may harm both mother and fetus. Breastfeeding women should also avoid internal use, as anthraquinones can pass into breast milk and cause diarrhea in infants. Topical application for skin infections may be acceptable but should be discussed with a healthcare provider.
Is Cassia alata effective for treating ringworm?
Cassia alata has been used traditionally across tropical regions as a primary treatment for ringworm (tinea corporis) and other fungal skin infections. Laboratory studies confirm antifungal activity against dermatophytes including Trichophyton and Microsporum species. The leaves are typically crushed and applied as a paste directly to the infection. While traditional evidence is strong across multiple cultures, clinical trial data remains limited. Evidence Level: C. It may serve as a complementary approach but should not replace prescribed antifungal medications for severe or persistent infections.
What are the side effects of taking Cassia alata internally?
Internal use of Cassia alata commonly causes gastrointestinal effects including abdominal cramping, diarrhea, and flatulence. Prolonged or excessive use can lead to electrolyte imbalances, particularly potassium depletion, which may cause muscle weakness and cardiac irregularities. Chronic laxative use can result in dependence, where the colon becomes unable to function normally without stimulation. Topical application may cause skin irritation or allergic reactions in sensitive individuals. Discontinue use if severe diarrhea, persistent cramping, or signs of electrolyte imbalance occur.
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Cassia alata (Senna alata) is a medicinal herb from the Leguminosae family used traditionally for skin diseases and constipation [PMID:19446609, PMID:32148534].
Contexte
Cassia alata, also known as candle bush, is a flowering shrub distributed in tropical and humid regions [PMID:32148534, PMID:36816058]. It is utilized in various traditional medicine systems, including the Creole system and Nigerian tradomedicine [PMID:19446609, PMID:41607176].
Usages traditionnels
Traditionally used to treat constipation, skin diseases (including ringworms, tinea infections, scabies, blotch, herpes, and eczema), typhoid, diabetes, malaria, asthma, and in ethnoveterinary medicine for dogs [PMID:19446609, PMID:32148534, PMID:10821961].
Composés actifs
Secondary metabolites include flavonoids (emodin, kaempferol, quercetin), anthraquinones (rhein, aloe-emodin), tannins, alkaloids (indole alkaloids), terpenes, saponins, phenolics, 1,8-cineole, caryophyllene, and limone [PMID:32148534, PMID:39381590, PMID:31002692, PMID:35630603]. Leaves are a significant source of propelargonidins [PMID:26566721].
Mécanisme d'action
Pharmacological activities are attributed to its array of secondary metabolites [PMID:32148534]. Specific mechanisms include the potential for enzyme inhibition in diabetes pathways [PMID:3041758도], modulation of the apoptotic pathway during coccidiosis [PMID:42082794], and upregulation of laminin-5, collagen IV, tropoelastin, and collagen III in skin models [PMID:40709743].
Preuves cliniques
Preuve DTinea imbricata
Application of leaf decoction for 4 weeks resulted in 95% of patients showing decreased pruritus VAS scores [PMID:32779266]
Preuve CConstipation
Laxative activity is supported by scientific findings [PMID:19446609]
Preuve DHelminthiasis (Earthworms)
Extract demonstrated anthelmintic efficacy comparable to albendazole, inducing faster paralysis and death times at 500 mg/ml [PMID:39360533]
Sécurité et effets indésirables
The species is considered safe for short-term or topical use [PMID:19446609].
Synthèse des preuves
Evidence consists primarily of review articles, in vitro studies, and animal models (mice, porcine), with limited clinical data from small case series or anecdotal reports. Strength of evidence is generally low to moderate.
2.PMID: 32148534 (2020) — Ethnobotanical Description and Biological Activities of Senna alata. · Evidence-based complementary and alternative medicine : eCAM
3.PMID: 32685725 (2020) — Chemical constituents, usage and pharmacological activity of Cassia alata. · Heliyon
4.PMID: 39360533 (2025) — Cassia alata: Helminth and Bacteria Fighter. · Combinatorial chemistry & high throughput screening
5.PMID: 27538998 (2016) — A Review of Flavonoids from Cassia Species and their Biological Activity. · Current pharmaceutical biotechnology
6.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
8.PMID: 40709743 (2025) — Real World Case Series: A.G.E. Interrupter Ultra Serum. · Journal of cosmetic dermatology
9.PMID: 36816058 (2023) — The complete chloroplast genome of Senna alata (L.) Roxb., an important medicinal plant from the Philippines. · Mitochondrial DNA. Part B, Resources
10.PMID: 42082794 (2026) — Regulation of the Apoptotic Modulatory Pathway During Eimeriosis by Cassia alata Extract. · Current microbiology
11.PMID: 30417583 (2019) — Enzymes inhibitors from natural sources with antidiabetic activity: A review. · Phytotherapy research : PTR
12.PMID: 10821961 (2000) — Medicinal plants used for dogs in Trinidad and Tobago. · Preventive veterinary medicine
13.PMID: 26566721 (2016) — Senna alata leaves are a good source of propelargonidins. · Natural product research
14.PMID: 41607176 (2026) — Evaluation of Antimalarial Activity of Senna alata and Influence on Hepatic Caspase-3 and Nuclear Factor Keppa B. · Parasite immunology
16.PMID: 25183125 (2014) — Broad spectrum anthelmintic potential of Cassia plants. · Asian Pacific journal of tropical biomedicine
17.PMID: 37210539 (2023) — Combination therapy: synergism among three plant extracts against selected pathogens. · BMC research notes
18.PMID: 35630603 (2022) — Indole Alkaloids and Chromones from the Stem Bark of Cassia alata and Their Antiviral Activities. · Molecules (Basel, Switzerland)
19.PMID: 32779266 (2020) — Senna (Cassia) alata (Linn.) Roxb. leaf decoction as a treatment for tinea imbricata in an indigenous tribe in Southern Philippines. · Mycoses
20.PMID: 31002692 (2019) — In vitro chondroprotective potential of Senna alata and Senna tora in porcine cartilage explants and their species differentiation by DNA barcoding-high resolution melting (Bar-HRM) analysis. · PloS one
21.PMID: 36080243 (2022) — Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food Ingredients as Complementary and Alternative Therapies for Atopic Dermatitis-A Comprehensive Review. · Molecules (Basel, Switzerland)
23.PMID: 36678812 (2023) — In Vitro Evaluation of Photodynamic Activity of Plant Extracts from Senna Species against Microorganisms of Medical and Dental Interest. · Pharmaceutics